ChemformationChemformation
Volume 15, Number 13
Friday, April 16, 1999
Chemformation is published by the Office of the Department Chairman. Please convey items of interest (or mailing list changes) to Linda Earle, Room 18-390, Department of Chemistry, MIT, Cambridge, MA 02139, 617/253-4080; 617/258-7500 (fax) or e-mail to lkn@mit.edu. Back issues of Chemformation can be accessed via the Chemistry Department Website.
Visit the Chemistry Department Website at http://web.mit.edu/chemistry/www/
|
Thursday, April 22, 1999 5:00 p.m. in MB23 Harvard MIT Physical Chemistry Seminar at Harvard Refreshments @ 4:30 p.m. in MB23 |
Professor Robert J. Silbey Mass. Institute of Technology "Spectroscopy in Low Temperature Solids: Photon Echos, Hole-Burning and Single Molecule Spectroscopy" |
|
Tuesday, April 27, 1999 9:30 a.m. in Room 6-120 Chemistry 5.561 Chemistry in Industry Lecture Series |
Dr. Robert A. Volkmann Pfizer Central Research "Discovery of an Amino Acid Peptide Isomerase¾ |
|
Tuesday, April 27, 1999 4:00 p.m. in Room 2-105 Seminar in Physical Chemistry Refreshments @ 4:00 p.m. in 6-233 |
Professor Michael Fayer Stanford University "Protein Dynamics: Ultrafast Infrared Vibrational Echo Experiments" |
|
Wednesday, April 28, 1999 4:00 p.m. in Room 6-120 Seminar in Inorganic Chemistry Refreshments @ 3:30 p.m. |
Ann Jones Davison Group "Rhenium and Technetium Coordination Chemistry: Applications in Radiopharmaceuticals" |
|
Tuesday, May 4, 1999 9:30 a.m. in Room 6-120 Chemistry 5.561 Chemistry in Industry Lecture Series |
Dr. Jeffrey H. Epstein-Toney Merck Research Laboratories "Merck¼s Armament Against Antibiotic Resistance: A Chemical Biology Approach" |
A special symposium in honor of the memory of George B¸chi will take place on Saturday, November 6, 1999. Speakers will include Professor Albert Eschenmoser, ETH, Switzerland and former Ph.D. students of Professor B¸chi: Dr. George M. Milne, President, Pfizer Central Research; Professor John C. Vederas, University of Alberta; Professor James D. White, Oregon State University; and Professor David R. Williams, Indiana University. For information, visit the B¸chi Memorial Symposium web site at: http://web.mit.edu/chemistry/www/buchi/buchiindex.html.
Massachusetts Institute of Technology
|
| April 27 |
Dr. Robert A. Volkmann Senior Research Fellow Pfizer Central Research "Discovery of an Amino Acid Peptide Isomerase" |
| May 4 |
Dr. Jeffrey H. Epstein-Toney Research Fellow in Endocrinology & Chemical Biology Merck Research Laboratories "Merck's Armament Against Antibiotic Resistance: A Chemical Biology Approach " |
| May 6 |
Dr. Steven A. King Project Leader, Department of Process Research Abbott Laboratories "Diastereo- and Enantioselective Synthesis of Highly Substituted Pyrrolidines Leading to Potent Endothelin Antagonists" |
| May 11 |
Dr. Kevin Chapman Senior Director, Medicinal Chemistry Merck Research Laboratories "Combinatorial Approaches to the Somatostatin Family of Receptors" |
Please join us on Saturday, May 1, 1999 for the Poster Session from 12-2 p.m. in room 56-154. The Senior Thesis Presentations will be held from 2-4 p.m., Room 56-114. Refreshments will be provided. Contact Prof. C. Cummins (ccummins@mit.edu) or Gabriella Browne (gbrowne@mit.edu).
Massachusetts Institute of Technology
|
|
Marc L. Snapper Boston College |
"New Strategies for the Synthesis of Biological Probe Reagents" |
|
Rick L. Danheiser Massachusetts Institute of Technology |
"Studies Directed Toward the Total Synthesis of Glycinoeclepin A" |
|
Stephen F. Martin University of Texas, Austin |
"Recent Advances in the Synthesis of Heterocyclic Natural Products" |
Massachusetts Institute of Technology
|
||||||||||||||||||||
|
Justin Miller Kemp Group |
"Efforts Towards the Total Synthesis of CP-263,114, A Highly Oxygenated Natural Product" |
|
Dana Buske Masamune Group |
"The Boron-Mediated Aldol Reaction of Carboxylic Esters" |
|
Greg Dudley Danheiser Group |
"Synthetic Approaches to Ascochlorin and Related Compounds" |
|
Ron Castellano Rebek Group |
"Reversibly-Formed Polymeric Capsules Based On Calixarenes" |
|
George Greco Schrock Group |
"Dinitrogen Activation by Molybdenum and Tungsten Complexes That Contain Aryl- Substituted Triamidoamine Ligands" |
|
|
|
|
Kevin Shea Danheiser Group |
"Synthesis and Properties of 9-Alkyl and -Aryl Cyclopenta[a]phenalene Derivatives" |
|
Marcus Hansen Buchwald Group |
"Recent Progress in Asymmetric Titanium-Catalyzed Imine Reduction" |
|
JosÈ Rivera-Ortiz Rebek Group |
"Chiral Spaces: Dissymmetric Capsules Through Self-Assembly" |
|
Dave Simone Swager Group |
"Synthesis, Binding Properties, and Electrochemical Studies of Crown Ethers, [2]-Catenanes, and [2]-Rotaxanes. Progress Towards Photoconducting Poly([2]-Catenanes) and Poly([n]-Rotaxanes)"/TD> |
Call Ed Udas at 253-4505 or stop by room 4-065 if students, faculty, or staff need help in organizing their MIT space.
Bob DiGiacomo will be coming in on Wednesdays or Thursdays to pick up any glass blowing work that you may have available. Please bring any work to room 4-064 or call Ed Udas or John Annese at 3-4505. Bob will do the work on a first-come, first-served basis.
The R.W. Johnson Pharmaceutical Research Institute, located in Raritan NJ, conducts pharmaceutical research in therapeutic areas including anti-infectives, central nervous system, dermatology and oncology. Scientist / Sr. Scientist. Become part of our prestigious Drug Discovery Research Organization, published in leading high impact scientific journals. The Growth Factors is a diverse group-seeking scientist with research interests in the area of hematology, oncology or diabetes. Solid expertise in signal transudation pathways, molecular pharmacology and animal model studies is a plus. The ideal applicant will possess a Ph.D. in Molecular Biology, Biochemistry or Pharmacology with 3-5 years' postdoctoral experience. Excellent communication, publication, computer skills, as well as the ability to work in a team environment are essential. Successful candidates will discover new chemical entities, which have an impact onkinases, phosphstses and proteases controlling growth differentiation of cells. Job Code:3159. Postdoctoral Scientist The Growth Factors team currently has a postdoctoral assignment, offering opportunities for publication I the area of hematology, oncology or diabetes. All assignments are 2 years and are renewable dependent upon performance. As a member of the team, you will contribute to the current drug discovery research programs and will assist in identifying new potential targets for assay development and screening Job Code: 3160 Please forward scannable resumes for the above positions, noting the job code to: Margaret Ruvoldt, Johnson & Johnson, JH 123, 501 George Street, New Brunswick, NJ 08901.
Return to Chemistry Department Home Page